Everyone wondering what Jeffrey Stein would do next after Cubist Pharmaceuticals acquired Trius Therapeutics has their answer: The former Trius president and CEO will lead the antifungal startup Cidara Therapeutics and bring colleagues from his prior post and other local companies to the new venture.
Dr Stein is president and CEO of San Diego-based Cidara, which recently closed a $32m Series A venture capital funding...


![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

